HighTower Advisors LLC increased its stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 17,371.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,348,416 shares of the medical equipment provider's stock after purchasing an additional 1,340,698 shares during the quarter. HighTower Advisors LLC owned 1.88% of Align Technology worth $178,523,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Align Technology in the 2nd quarter worth $745,370,000. Assenagon Asset Management S.A. lifted its holdings in Align Technology by 638.7% in the third quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider's stock valued at $629,469,000 after acquiring an additional 4,031,284 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its holdings in Align Technology by 3,162.7% in the third quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider's stock valued at $278,342,000 after acquiring an additional 2,033,451 shares during the period. Vontobel Holding Ltd. lifted its holdings in Align Technology by 69,628.9% in the third quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider's stock valued at $183,335,000 after acquiring an additional 1,383,526 shares during the period. Finally, Danske Bank A S boosted its position in Align Technology by 1,366,764.0% in the third quarter. Danske Bank A S now owns 683,432 shares of the medical equipment provider's stock worth $90,426,000 after purchasing an additional 683,382 shares during the last quarter. Hedge funds and other institutional investors own 88.43% of the company's stock.
Align Technology Stock Down 1.5%
NASDAQ ALGN opened at $163.46 on Wednesday. The stock's 50-day moving average price is $152.02 and its 200-day moving average price is $168.57. Align Technology, Inc. has a 52 week low of $130.23 and a 52 week high of $200.43. The company has a market capitalization of $11.52 billion, a P/E ratio of 17.79, a price-to-earnings-growth ratio of 2.15 and a beta of 1.74.
Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.77 by $0.03. The firm had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1 billion. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The business's quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.61 EPS. Research analysts anticipate that Align Technology, Inc. will post 9.21 EPS for the current year.
Analysts Set New Price Targets
Several research analysts have issued reports on the company. Morgan Stanley dropped their target price on Align Technology from $188.00 to $175.00 and set an "equal weight" rating on the stock in a research report on Thursday, October 29th. Evercore lowered shares of Align Technology from an "outperform" rating to an "in-line" rating and set a $155.00 price target for the company. in a research report on Monday, October 5th. Zacks Research upgraded shares of Align Technology from a "strong sell" rating to a "hold" rating in a research note on Friday, November 13th. Stifel Nicolaus dropped their price objective on shares of Align Technology from $210.00 to $175.00 and set a "buy" rating on the stock in a report on Friday, October 9th. Finally, Weiss Ratings upgraded shares of Align Technology from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, Align Technology currently has an average rating of "Moderate Buy" and a consensus target price of $193.08.
Get Our Latest Stock Report on ALGN
Align Technology Profile
(
Free Report)
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Align Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.
While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.